| Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint … DF Hanley, RE Thompson, M Rosenblum, G Yenokyan, K Lane, N McBee, ... The Lancet 393 (10175), 1021-1032, 2019 | 764 | 2019 |
| Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial DF Hanley, K Lane, N McBee, W Ziai, S Tuhrim, KR Lees, J Dawson, ... The Lancet 389 (10069), 603-611, 2017 | 454 | 2017 |
| Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema WA Mould, JR Carhuapoma, J Muschelli, K Lane, TC Morgan, NA McBee, ... Stroke 44 (3), 627-634, 2013 | 414 | 2013 |
| Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial DF Hanley, RE Thompson, J Muschelli, M Rosenblum, N McBee, K Lane, ... The Lancet Neurology 15 (12), 1228-1237, 2016 | 386 | 2016 |
| Early outpatient treatment for Covid-19 with convalescent plasma DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ... New England Journal of Medicine 386 (18), 1700-1711, 2022 | 250 | 2022 |
| Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial N Naff, MA Williams, PM Keyl, S Tuhrim, MR Bullock, SA Mayer, W Coplin, ... Stroke 42 (11), 3009-3016, 2011 | 197 | 2011 |
| ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for brain hemorrhage: a multicenter randomized controlled trial P Vespa, D Hanley, J Betz, A Hoffer, J Engh, R Carter, P Nakaji, C Ogilvy, ... Stroke 47 (11), 2749-2755, 2016 | 181 | 2016 |
| A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) WC Ziai, S Tuhrim, K Lane, N McBee, K Lees, J Dawson, K Butcher, ... International Journal of Stroke 9 (4), 536-542, 2014 | 141 | 2014 |
| Surgical performance determines functional outcome benefit in the minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage … IA Awad, SP Polster, J Carrión-Penagos, RE Thompson, Y Cao, A Stadnik, ... Neurosurgery 84 (6), 1157-1168, 2019 | 130 | 2019 |
| Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated … M Dey, A Stadnik, F Riad, L Zhang, N McBee, C Kase, JR Carhuapoma, ... Neurosurgery 76 (3), 291-301, 2015 | 91 | 2015 |
| One-year outcome trajectories and factors associated with functional recovery among survivors of intracerebral and intraventricular hemorrhage with initial severe disability VA Shah, RE Thompson, G Yenokyan, JN Acosta, R Avadhani, R Dlugash, ... JAMA neurology 79 (9), 856-868, 2022 | 73 | 2022 |
| Atorvastatin treatment of cavernous angiomas with symptomatic hemorrhage exploratory proof of concept (AT CASH EPOC) trial SP Polster, A Stadnik, AL Akers, Y Cao, GA Christoforidis, MD Fam, ... Neurosurgery 85 (6), 843-853, 2019 | 73 | 2019 |
| Intracranial hypertension and cerebral perfusion pressure insults in adult hypertensive intraventricular hemorrhage: occurrence and associations with outcome WC Ziai, CB Thompson, S Mayo, N McBee, WD Freeman, R Dlugash, ... Critical care medicine 47 (8), 1125-1134, 2019 | 62 | 2019 |
| Surgical performance in minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage evacuation phase III clinical trial MD Fam, D Hanley, A Stadnik, HA Zeineddine, R Girard, M Jesselson, ... Neurosurgery 81 (5), 860-866, 2017 | 62 | 2017 |
| Intracerebral hemorrhage volume reduction and timing of intervention versus functional benefit and survival in the MISTIE III and STICH trials SP Polster, J Carrión-Penagos, SB Lyne, BA Gregson, Y Cao, ... Neurosurgery 88 (5), 961-970, 2021 | 51 | 2021 |
| Influence of intracerebral hemorrhage location on outcomes in patients with severe intraventricular hemorrhage V Eslami, P Tahsili-Fahadan, L Rivera-Lara, D Gandhi, H Ali, ... Stroke 50 (7), 1688-1695, 2019 | 51 | 2019 |
| CSF inflammatory response after intraventricular hemorrhage MD Fam, HA Zeineddine, JK Eliyas, A Stadnik, M Jesselson, N McBee, ... Neurology 89 (15), 1553-1560, 2017 | 50 | 2017 |
| Randomized controlled trial of early outpatient COVID-19 treatment with high-titer convalescent plasma DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ... Medrxiv, 2021 | 49 | 2021 |
| Trial readiness in cavernous angiomas with symptomatic hemorrhage (CASH) SP Polster, Y Cao, T Carroll, K Flemming, R Girard, D Hanley, N Hobson, ... Neurosurgery 84 (4), 954-964, 2019 | 41 | 2019 |
| Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial SB Murthy, I Awad, S Harnof, F Aldrich, M Harrigan, J Jallo, JL Caron, ... Neurology 89 (4), 355-362, 2017 | 34 | 2017 |
